First Trust NYSE Arca Biotechnology Index Fund FBT
269.94 USD -1.09 (-0.40%)
As ofNov 16, 2026, 11:49 AM EST
269.35 Day range 271.43
190.23 52-week range 280.30
- YTD
- +30.71%
- 1 year
- +35.07%
- Assets
- $3.03B
- Expense ratio
- 0.55%
- NAV
- 271.49
- Holdings
- 30
- Top 10 weight
- 39.2%
- Asset class
- Sector Equity
- Issuer
- First Trust
- Inception
- Jun 19, 2006
- YTD return
- +30.71%
- 1-year return
- +35.07%
- Volume
- 28.77K
- Avg volume
- 70.50K
- Open
- 270.32
- Previous close
- 271.03
- Day's range
- 269.35 – 271.43
- 52-week range
- 190.23 – 280.30
- 50-day average
- 269.44
- 200-day average
- 235.47
5D +5.02 (+1.89%)
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
News
Better Biotech ETF: First Trust's FBT vs. Invesco's PBE
Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT?
Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT?
Your note
Sign in to keep a note on FBT — it syncs with the Stock Master app.
